Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-004328
Filing Date
2022-04-28
Accepted
2022-04-28 20:54:58
Documents
1
Period of Report
2022-04-26

Document Format Files

Seq Description Document Type Size
1 form4-04282022_050458.html 4  
1 form4-04282022_050458.xml 4 5643
  Complete submission text file 0001415889-22-004328.txt   7043
Mailing Address C/O VENTIV HEALTH 200 COTTONTAIL LN. VANTAGE COURT N. SOMERSET NJ 08873
Business Address
BROSHY ERAN (Reporting) CIK: 0001256230 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36033 | Film No.: 22869513

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations